Generics in the Budget


This seems like good news:

Makers of generic drugs hailed a proposal in President Barack Obama’s budget to set up a faster pathway for generic versions of biologic drugs, the fastest-growing segment of the pharmaceutical industry.

The budget included other steps friendly to generics makers. The administration said it wants to end “evergreening,” in which brand-name makers reformulate existing products and extend the life of their market exclusivity.

The proposals on generic drugs are part of a series of spending curbs that the president is proposing, all aimed at helping to reduce costs in the health care system overall and to pay for his effort to expand coverage to all Americans.

This is a small-bore initiative.  But put enough small-bore initiatives together, and eventually you can have something pretty big.

Fact:

Mother Jones was founded as a nonprofit in 1976 because we knew corporations and the wealthy wouldn’t fund the type of hard-hitting journalism we set out to do.

Today, reader support makes up about two-thirds of our budget, allows us to dig deep on stories that matter, and lets us keep our reporting free for everyone. If you value what you get from Mother Jones, please join us with a tax-deductible donation so we can keep on doing the type of journalism that 2018 demands.

Donate Now